Cargando...
Cytosolic processing governs TAP-independent presentation of a critical melanoma antigen
Cancer immunotherapy has been flourishing in recent years with remarkable clinical success. But as more patients are treated, a shadow is emerging that has haunted other cancer therapies: tumors develop resistance. Resistance is often caused by defects in the MHC class I (MHC I) antigen presentation...
Gardado en:
| Publicado en: | J Immunol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457910/ https://ncbi.nlm.nih.gov/pubmed/30135181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1701479 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|